Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Cara Therapeutics, Inc. (CARA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2023 Financial Results"
03/06/2023 8-K Quarterly results
Docs: "Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results"
11/07/2022 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2022 Financial Results"
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
Docs: "Cara Therapeutics Reports First Quarter 2022 Financial Results"
03/01/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2021 Financial Results"
05/10/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2020 Financial Results"
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
02/27/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2019 Financial Results"
08/07/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of The Securities Exchange Act of 1934 Date of Report August 7, 2019 CARA THERAPEUTICS, INC. Delaware 001-36279 75-3175693 4 Stamford Plaza 107 Elm Street, 9th Floor Stamford, Connecticut 06902 Registrant's telephone number, including area code 406-3700",
"Cara Therapeutics Reports Second Quarter 2019 Financial Results"
05/07/2019 8-K Quarterly results
Docs: "Cara Therapeutics Reports First Quarter 2019 Financial Results"
03/12/2019 8-K Quarterly results
Docs: "Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results"
11/06/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of The Securities Exchange Act of 1934 Date of Report November 6, 2018 CARA THERAPEUTICS, INC. Delaware 001-36279 75-3175693 4 Stamford Plaza 107 Elm Street, 9th Floor Stamford, Connecticut 06902 Registrant's telephone number, including area code 406-3700",
"Cara Therapeutics Reports Third Quarter 2018 Financial Results"
08/07/2018 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2018 Financial Results"
05/09/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of The Securities Exchange Act of 1934 Date of Report May 9, 2018 CARA THERAPEUTICS, INC. Delaware 001-36279 75-3175693 4 Stamford Plaza 107 Elm Street 9th Floor Stamford, Connecticut 06902",
"Cara Therapeutics Reports First Quarter 2018 Financial Results"
03/15/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of The Securities Exchange Act of 1934 Date of Report March 15, 2018 CARA THERAPEUTICS, INC. Delaware 001-36279 75-3175693 4 Stamford Plaza 107 Elm Street 9th Floor Stamford, Connecticut 06902 Registrant's telephone number, including area code 406-3700",
"Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results"
11/02/2017 8-K Quarterly results
08/03/2017 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of The Securities Exchange Act of 1934 Date of Report August 3, 2017 CARA THERAPEUTICS, INC. Delaware 001-36279 75-3175693 4 Stamford Plaza 107 Elm Street 9th Floor Stamford, Connecticut 06902 Registrant's telephone number, including area code 406-3700",
"Cara Therapeutics Reports Second Quarter 2017 Financial Results"
05/04/2017 8-K Form 8-K - Current report
03/09/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/04/2016 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2016 Financial Results"
05/05/2016 8-K Form 8-K - Current report
03/10/2016 8-K Form 8-K - Current report
11/09/2015 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2015 Financial Results"
08/10/2015 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2015 Financial Results"
05/12/2015 8-K Quarterly results
Docs: "Cara Therapeutics Reports First Quarter 2015 Financial Results - End-of-Phase 2 meeting with FDA informs Phase 3 clinical development program for novel kappa opioid, I.V. CR845 -"
03/26/2015 8-K Quarterly results
Docs: "Cara Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results"
11/10/2014 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2014 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy